


|
The European market of medical technologies is valued at about 55.2 billion € (Eucomed sources) and has a constant growth of 7% per year. |
|
| MedC.Partners address medical technology companies’ needs. Regulatory and Reimbursement are integral and critical elements of healthcare companies in the European market and can no longer be managed separately from Marketing. Companies’ development must take into account several stakeholder objectives: Authorities in terms of regulation and reduction of healthcare expenditure
Physicians in terms of innovation
Patients in terms of information and transparency
Investors’ expectations |
||